Human gene engineering insulins and drugs for the restoration of the central nervous system
Geropharm LLC is engaged in development and release of Russian innovative drugs for the treatment of socially significant diseases and generics of higher-priority from the import substitution point of view. Company strategic aims coincide with the primary goals challenging the branch in the context of state federal programs «PHARMA-2020», «BIO-2020».
At present time there are under development drugs for the diabetes treatment, including analogue insulins, nootropic drugs, drugs for dementias and craniocerebral traumas treatment, urological drugs. In total, there are more than 20 projects at various stages and part of them is realized within the framework of federal programs of The Ministry of Industry and Trade and The Ministry of Education and Science.
Company portfolio includes:
human gene engineering insulins,
original Russian drugs designed for the restoration of the central nervous system
drugs restoration of retina of an eye functions.
The geography of distribution of the company drugs includes Russia, countries of CIS and the near abroad.
Number of employees: 600
Fill in your address into the address field below the map and the shortest route will be calculated.